Miller/Howard Investments »

Catalyst Pharmaceutical Partners shares owned by Miller/Howard Investments

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Miller/Howard Investments from 13F filings

Historical chart of Miller/Howard Investments investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Miller/Howard Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Miller/Howard Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $545k 32k 16.81
2023-09-30 $375k 32k 11.69
2023-06-30 $432k 32k 13.44
2023-03-31 $529k 32k 16.58
2022-12-31 $587k 32k 18.60
2022-09-30 $405k 32k 12.83
2022-06-30 $221k 32k 7.02

More positions owned by Miller/Howard Investments

Mplx (MPLX)
Johnson & Johnson (JNJ)
Enterprise Products Partners (EPD)
Cisco Systems (CSCO)
Abbvie (ABBV)
Old Republic International Corporation (ORI)
Energy Transfer Equity (ET)
GSK Adr (GSK)
Gilead Sciences (GILD)
State Street Corporation (STT)
iShares Dow Jones Select Dividend (DVY)
Medtronic (MDT)
East West Ban (EWBC)
Citigroup (C)
Exelon Corporation (EXC)

View all positions for Miller/Howard Investments

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management
Northern Trust

View all funds holding Catalyst Pharmaceutical Partners